CAMK4 and systemic lupus erythematosus: CaMK4 activates AKT/mTOR pathway but is also found to promote glycolysis by binding and augmenting the activity of pyruvate kinase M2, the final rate-limiting enzyme in glycolysis, underlying autoimmunity associated with Th17 in SLE [78,79].